ClinicalTrials.gg
Active, not recruitingNCT04988451FASLUpdated Jul 11, 2025

Family ASL: Longitudinal Study of Deaf Children and Hearing Parents Who Receive Services to Support the Learning of ASL

An interventional study of ASL Services in Deafness and Hearing Loss, sponsored by University of Connecticut. Active, not recruiting at 1 site in United States. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2025-07-11.

Sponsored by University of Connecticut · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Nov 2025, 11 months ago, but the record still lists the study as active, not recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Non-randomized
Ages
2 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 63 studies in Deafness with a site in United States — 19 open to participants now, 22 under way, 1 of them phase 3. Deafness · United States.

Planned enrollment
23rd of 44
40 · median 41
Started
2021
with 2 others
No phase
31 of 63
10 open now
Primary completion
2025-11
later than 2 of 21 live
Registered
41st of 63
by date

Among the 63 studies in Deafness with a site in United States, this one is the 23rd largest by planned enrollment of the 44 interventional ones that give a count, is one of 3 that started in 2021, is one of 31 with no phase, reaches primary completion later than 2 of the 21 other live ones, and was the 41st registered.

Deafness

161 studies on the registry are indexed under Deafness; 46 are open to participants now.

Browse Deafness studies →

Open to participants now

19 of the 63 studies in Deafness with a site in United States are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 30 Deafness studies recruiting now, 11 (37%) set no upper age limit and 10 (33%) stop at 75 or younger; 19 take children under 18; 5 take healthy volunteers.

This study: 2 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 63 studies in Deafness with a site in United States, or all of them as a file.
02

Study summary

This study examines the development of American Sign Language by deaf and hard of hearing (DHH) children and their parents.

Read the detailed description

After being informed about the study and potential risks, adult participants who give written informed consent and children whose parents who give written permission will be enrolled in the study. They will participate in preliminary language tasks to assess baseline performance on American Sign Language (ASL) measures. Subsequently they will have weekly sessions with an ASL Specialist to support their development of ASL, following a 6-week on/6-week off ABABABAB sequence.

03

Conditions studied

  • Deafness
  • Hearing Loss

Keywords

  • language
  • sign language
  • language development
  • child language
  • child, preschool
  • parents
  • caregivers
04

Who can participate

Ages eligible
2 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Children:

  • Children ages 2;00 - 2;11 at the start of the longitudinal project
  • Child is Deaf/ Hard-of-Hearing
  • Participating in a program utilizing a bimodal bilingual philosophy

Adults:

- One adult caregiver for each child

Exclusion criteria

Exclusion Criteria:

  • Children with previously-diagnosed conditions other than deafness known to affect language and cognitive development
  • Families without access to internet (at home or other locations)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    ASL Services - Adult ASL Development

    Presence (or absence, across 6-week periods) of ASL services designed to support improvement in ASL fluency

    Behavioral: ASL Services

  • Experimental
    ASL Services - Child Language Development

    Presence (or absence, across 6-week periods) of ASL services designed to support improvement in ASL fluency

    Behavioral: ASL Services

Interventions

  • BehavioralASL Services

    ASL specialist meets with participants and provides ASL instruction

06

What researchers measure

Primary outcomes

  1. Change from Baseline in ASL Phonological Production Accuracy over 12 Months

    Participants copy ASL signs produced on video; their productions are scored for phonological accuracy and reported as percent correct out of all possible phonological features. Weekly measures are taken for SCD analysis.

    Time frame: Baseline and 12 months

Secondary outcomes

  1. Change from Baseline in ASL Production Frequency over 12 Months

    Participants engage in naturalistic play sessions which are videorecorded. Sessions are analyzed for the number of productions in ASL over a 15-minute period. Weekly measures are taken for SCD analysis.

    Time frame: Baseline and 12 months

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Yes — De-identified data from language tasks

Time frame: After (or with) publication of the results

Access criteria: De-identified numerical coding scores will be shared using an open science site that is generally accessible

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2021 (actual). Primary completion is estimated for Nov 2025, 52 months after the start.

Of 50 non-industry interventional studies with no phase under Deafness, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 20. This study's planned 52 months is above that.

Counting every sponsor, half of 58 studies reached it within 31 months; a quarter within 17.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 26, 2021
First posted
Aug 3, 2021
StartActual
Jul 20, 2021
Primary completionEst.
Nov 30, 2025
CompletionEst.
Nov 30, 2025
Last update
Jul 11, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04988451
Responsible party
Diane Lillo-Martin (BOT Distinguished Professor, University of Connecticut) — Principal investigator
First posted
Aug 3, 2021
Start date
Jul 20, 2021
Primary completion
Nov 30, 2025 (estimated)
Completion
Nov 30, 2025 (estimated)
Last update
Jul 11, 2025

Study contacts

Diane C Lillo-Martin, Ph.D.
principal investigator · University of Connecticut

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion